UBS Group AG - VIRIOS THERAPEUTICS INC ownership

VIRIOS THERAPEUTICS INC's ticker is VIRI and the CUSIP is 92829J104. A total of 14 filers reported holding VIRIOS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of VIRIOS THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$366
-39.0%
265
-83.8%
0.00%
Q1 2023$600
-96.2%
1,636
-96.0%
0.00%
Q3 2022$16,000
-74.6%
41,041
+190.3%
0.00%
Q1 2022$63,000
+425.0%
14,137
+528.3%
0.00%
Q4 2021$12,000
-85.7%
2,250
-83.1%
0.00%
Q2 2021$84,000
+236.0%
13,316
+300.8%
0.00%
Q4 2020$25,0003,3220.00%
Other shareholders
VIRIOS THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
McCollum Christoferson Group LLC 33,300$30,7960.01%
&PARTNERS 11,000$10,1730.01%
Virtu Financial LLC 27,322$250.00%
XTX Topco Ltd 14,441$13,3550.00%
RAYMOND JAMES & ASSOCIATES 30,000$27,7440.00%
WELLS FARGO & COMPANY/MN 124$1150.00%
NORTHERN TRUST CORP 24,035$22,2280.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 11,482$10,6190.00%
GEODE CAPITAL MANAGEMENT, LLC 174,469$161,3750.00%
View complete list of VIRIOS THERAPEUTICS INC shareholders